These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9024028)

  • 1. RB 101, a purported pro drug inhibitor of enkephalin metabolism, is antinociceptive in pregnant mice.
    Jayaram A; Singh P; Noreuil T; Fournié-Zaluski MC; Carp HM
    Anesth Analg; 1997 Feb; 84(2):355-8. PubMed ID: 9024028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine.
    Noble F; Turcaud S; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1992 Nov; 223(1):83-9. PubMed ID: 1478260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
    Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
    Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation.
    Maldonado R; Valverde O; Turcaud S; Fournié-Zaluski MC; Roques BP
    Pain; 1994 Jul; 58(1):77-83. PubMed ID: 7970841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCH 32615, an enkephalinase inhibitor, enhances pregnancy-induced analgesia in mice.
    Jayaram A; Singh P; Carp H
    Anesth Analg; 1995 May; 80(5):944-8. PubMed ID: 7726437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioids.
    Valverde O; Fournié-Zaluski MC; Roques BP; Maldonado R
    Eur J Pharmacol; 1996 Sep; 312(1):15-25. PubMed ID: 8891574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
    Maldonado R; Valverde O; Ducos B; Blommaert AG; Fournie-Zaluski MC; Roques BP
    Br J Pharmacol; 1995 Mar; 114(5):1031-9. PubMed ID: 7780637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding.
    Ruiz-Gayo M; Baamonde A; Turcaud S; Fournie-Zaluski MC; Roques BP
    Brain Res; 1992 Feb; 571(2):306-12. PubMed ID: 1319268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management.
    Nieto MM; Wilson J; Walker J; Benavides J; Fournié-Zaluski MC; Roques BP; Noble F
    Neuropharmacology; 2001 Sep; 41(4):496-506. PubMed ID: 11543770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation.
    Noble F; Fournié-Zaluski MC; Roques BP
    Neuropharmacology; 1994 Jan; 33(1):135-40. PubMed ID: 7910383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
    Valverde O; Blommaert AG; Fournié-Zaluski MC; Roques BP; Maldonado R
    Eur J Pharmacol; 1995 Nov; 286(1):79-93. PubMed ID: 8566154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.
    Ruiz F; Fournié-Zaluski MC; Roques BP; Maldonado R
    Br J Pharmacol; 1996 Sep; 119(1):174-82. PubMed ID: 8872371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.
    Boudinot E; Morin-Surun M; Foutz AS; Fournié-Zaluski M; Roques BP; Denavit-Saubié M
    Pain; 2001 Feb; 90(1-2):7-13. PubMed ID: 11166965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect.
    Valverde O; Noble F; Beslot F; Daugé V; Fournié-Zaluski MC; Roques BP
    Eur J Neurosci; 2001 May; 13(9):1816-24. PubMed ID: 11359533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
    Maldonado R; Derrien M; Noble F; Roques BP
    Neuroreport; 1993 Jul; 4(7):947-50. PubMed ID: 8369487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
    Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
    Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice.
    Noble F; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1993 Jan; 230(2):139-49. PubMed ID: 8422896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.